“Reverse Chocolate for Dry Eye” Los Angeles-based start-up, AesculaTech, Inc., is developing a platform of temperature-responsive smart materials, including their first product, AesculaGel, a punctal plug for the treatment of dry eye syndrome that is applied as a liquid then solidifies at body temperature and blocks tear ducts. In this interview, co-founder Andrew Bartynski talks about his experiences in getting the company and its technology where it is and what’s next for AesculaTech.
“Robots Hug the Heart for HF Relief” Houston-based start-up, CorInnova Inc., is developing a minimally invasive soft robotic cardiac device that they anticipate will shift the paradigm of existing heart failure (HF) treatments, and may reverse the progression of HF or even prevent its development in post-heart attack patients. In this interview, CEO William Altman and Senior Biomedical Engineer Christina Bolch talk about their experiences in getting the company and its technology where it is and what’s next for CorInnova.
“VerteCore: Wearable Spinal Decompression” Mississippi medical device start-up, VerteCore Technologies LLC, has developed VerteCore Lift, a wearable orthopedic device, to innovate the way back pain is managed. The device alleviates nerve root impingement related sciatica and neurogenic intermittent claudication that results from spinal stenosis with mobile, non-surgical decompression. In this interview, co-founder and CEO, Paul Leake talks about his experiences in co-founding the company and what’s next for VerteCore.
“LabReady, Set, Go: Accurately Diagnosing Infections Faster and From Home” Houston medical device diagnostics start-up, Vax-Immune Diagnostics LLC, has developed LabReady, a hand-held, portable, disposable device. This novel diagnostic platform device was designed to revolutionize the identification process of infectious disease. In this interview, co-founder, President, and CTO Leonard Weisman, MD talks about his experiences in co-founding the company and what’s next for Vax-Immune.
“A Hole in the Heart Alleviates HF Symptoms” Houston medical device start-up, Alleviant Medical, is developing a novel transcatheter technology that applies left atrial decompression to provide symptomatic relief for congestive heart failure. In this interview, co-founder and CMO Jacob Kriegel, MD talks about his experiences in co-founding the company and what’s next for Alleviant Medical.
“NeuroQore’s Electromagnetics: A New Way to Treat Depression & Neurobehavioral Disorders” Silicon Valley medical device start-up, NeuroQore Inc., has developed a novel platform technology that it believes can be applied to many neurobehavioral disorders and could provide rapid treatment for major depressive disorder (MDD). The team is striving to put an end to the most devastating of all endings: suicide. In this interview, co-founder and CEO Mehran Talebinejad talks about his experiences in co-founding the company and what’s next for NeuroQore.
“OtoSet: Sonicare for the Ears” An Arizona-based medical device start-up SafKan Inc is pursuing an alternative to the current standard-of-care for excess or impacted earwax— unchallenged for nearly two centuries—with the world’s first automated ear cleaning device for clinical use, the OtoSet. In this interview, co-founder and CEO Sahil Diwan talks about his experiences in co-founding the company and what’s next for SafKan.
“When One Door Closes Another Door Opens: The Story of Telluride Medical Partners.” Emerging Arizona-based medical device accelerator Telluride Medical Partners LLC (TMP) is comprised of business entrepreneurs, medical device start-up experts, and medtech engineers who are committed to bringing disruptive technologies to market. In this candid interview, Founder and CEO Eric Wells talks about his early career, his experiences in founding the company, and what’s next for TMP.
“Sana’s Wearable Solution for Chronic Pain” Boulder, CO-based start-up Sana Health is taking on one of the biggest health crises in the world today: opioid use, as part of a larger mission to redefine the way pain is treated. Sana’s novel FlowState technology induces deep relaxation, promotes neuroplasticity, reduces pain, and triggers sleep in as little as 10 minutes. In this interview, Founder Richard Hanbury talks about his experiences in founding the company and what’s next for Sana Health.
“Billy Cohn, MD: Making Medtech Makers at Johnson & Johnson’s CDI @TMC” In this candid video interview onsite at the Center for Device Innovation in Houston, TX, Billy Cohn, MD, VP of Johnson & Johnson’s Medical Device Companies and Director, CDI @ TMC reflects on his extensive device patent journey and shares the keys to overcoming the never-ending challenges that plague device innovation.
“FineHeart: A Disruptively Simple Solution for Advanced Heart Failure” France-based FineHeart SA aims to make an impact on the second leading cause of death in the US and in Europe: heart failure (HF) with its first patented product ICOMS. The ICOMS is a hybrid system composed of a pulsatile smart pump, an electrical synchronization module, a control board, and an energy module powered by a TET system. In this interview, CEO Arnaud Mascarell talks about his early inspiration, his experiences in co-founding the company and what’s next for FineHeart.
“Day Zero Diagnostics: Modernizing Infectious Disease Diagnosis” Boston-based start-up Day Zero Diagnostics is developing a sequencing-based rapid diagnostic that identifies both the species and the antibiotic resistance profile of a bacterial pathogen in only hours, not days, which for patients could mean the difference between life or death. In this interview, CEO and Co-founder Jong Lee, MBA talks about his early inspiration and his experiences in co-founding the company, his current priorities, and what’s next for Day Zero.
“Briteseed’s Burgeoning Smart Surgical Tools Stop Unsafe Bleeding.” Chicago-based Briteseed LLC is developing the next generation of smart surgical tools that can provide visual, anatomical information to surgeons in real-time. In addition to improving patient outcomes, Jonathan believes Briteseed could offer significant cost savings for payors and providers impacted by non-reimbursable costs. In this interview, CEO Jonathan Gunn, Phd, JD, talks about his early inspiration and his experiences in co-founding the company, his current priorities, and what’s next for Briteseed.
gBETA Medtech Accelerator, launched this past March, is the first accelerator of its kind to tap into the rich medical device, digital healthcare, diagnostics and biotech ecosystem that exists in the Midwest Medical Alley region. Its goal is community building, and fostering innovation among the most promising of today’s early-stage start-ups. The program is funded by Boston Scientific, with additional support from Mayo Clinic, University of Minnesota, and Medical Alley Association.
“Conavi: Completing the Picture for Intravascular Imaging.” Toronto-based commercial-stage medical device company Conavi Medical is developing image guidance technologies for use in minimally invasive cardiovascular procedures and is on a mission “to make procedures that are established or emerging safer, faster, and with better outcomes.” In this interview, Brian talks about his inspiration and early experiences in founding the company, his current priorities, and what’s next for Conavi.
“From Railroads to Robots: The Story Behind Deneb Medical.” Spain-based start-up Deneb Medical is developing a surgical robot for selective tissue ablation called CoBot, which the Co-founders believe will directly reduce the risk of unintended damage to critical anatomical structures. In this candid interview, the Co-founders talk about their inspiration and early experiences in founding the company, their current priorities, and what’s next.
London-based oncology diagnostics start-up BeamLine Diagnostics is developing a point-of-care (POC) biopsy triaging and stratification system, called Solas. Solas is estimated to reduce the total number of samples within pathology by approximately 50%, alleviating current system stress. In this candid interview, co-Founder & CEO Dr. Liberty Foreman talks about her inspiration and early experiences in founding the company, her current priorities, and what’s next for BeamLine.